314 related articles for article (PubMed ID: 29330456)
1. 20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1.
Tunaru S; Bonnavion R; Brandenburger I; Preussner J; Thomas D; Scholich K; Offermanns S
Nat Commun; 2018 Jan; 9(1):177. PubMed ID: 29330456
[TBL] [Abstract][Full Text] [Related]
2. Suppression of free fatty acid receptor 1 expression in pancreatic β-cells in obese type 2 diabetic db/db mice: a potential role of pancreatic and duodenal homeobox factor 1.
Kohara K; Obata A; Kimura T; Shimoda M; Moriuchi S; Okauchi S; Hirukawa H; Mune T; Kaku K; Kaneto H
Endocr J; 2019 Jan; 66(1):43-50. PubMed ID: 30333365
[TBL] [Abstract][Full Text] [Related]
3. Glucose-stimulated insulin secretion depends on FFA1 and Gq in neonatal mouse islets.
Lorza-Gil E; Kaiser G; Carlein C; Hoffmann MDA; König GM; Haug S; Prates Roma L; Rexen Ulven E; Ulven T; Kostenis E; Birkenfeld AL; Häring HU; Ullrich S; Gerst F
Diabetologia; 2023 Aug; 66(8):1501-1515. PubMed ID: 37217659
[TBL] [Abstract][Full Text] [Related]
4. FFAR1 is involved in both the acute and chronic effects of palmitate on insulin secretion.
Kristinsson H; Smith DM; Bergsten P; Sargsyan E
Endocrinology; 2013 Nov; 154(11):4078-88. PubMed ID: 24035997
[TBL] [Abstract][Full Text] [Related]
5. 20-HETE attenuates the response of glucose-stimulated insulin secretion through the AKT/GSK-3β/Glut2 pathway.
Zhang B; Lai G; Wu J; Sun R; Xu R; Yang X; Qi Y; Zhao Y
Endocrine; 2016 Nov; 54(2):371-382. PubMed ID: 27568038
[TBL] [Abstract][Full Text] [Related]
6. Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans.
Wagner R; Kaiser G; Gerst F; Christiansen E; Due-Hansen ME; Grundmann M; Machicao F; Peter A; Kostenis E; Ulven T; Fritsche A; Häring HU; Ullrich S
Diabetes; 2013 Jun; 62(6):2106-11. PubMed ID: 23378609
[TBL] [Abstract][Full Text] [Related]
7. A novel antidiabetic drug, fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1.
Yabuki C; Komatsu H; Tsujihata Y; Maeda R; Ito R; Matsuda-Nagasumi K; Sakuma K; Miyawaki K; Kikuchi N; Takeuchi K; Habata Y; Mori M
PLoS One; 2013; 8(10):e76280. PubMed ID: 24130766
[TBL] [Abstract][Full Text] [Related]
8. Palmitic acid-induced lipotoxicity promotes a novel interplay between Akt-mTOR, IRS-1, and FFAR1 signaling in pancreatic β-cells.
Marafie SK; Al-Shawaf EM; Abubaker J; Arefanian H
Biol Res; 2019 Aug; 52(1):44. PubMed ID: 31426858
[TBL] [Abstract][Full Text] [Related]
9. Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.
Sabrautzki S; Kaiser G; Przemeck GKH; Gerst F; Lorza-Gil E; Panse M; Sartorius T; Hoene M; Marschall S; Häring HU; Hrabě de Angelis M; Ullrich S
Mol Metab; 2017 Oct; 6(10):1304-1312. PubMed ID: 29031729
[TBL] [Abstract][Full Text] [Related]
10. The HETE Is on FFAR1 and Pancreatic Islet Cells.
Trauelsen M; Lückmann M; Frimurer TM; Schwartz TW
Cell Metab; 2018 Feb; 27(2):273-275. PubMed ID: 29414682
[TBL] [Abstract][Full Text] [Related]
11. Activation of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) by free fatty acid receptor 1 (FFAR1/GPR40) protects from palmitate-induced beta cell death, but plays no role in insulin secretion.
Panse M; Gerst F; Kaiser G; Teutsch CA; Dölker R; Wagner R; Häring HU; Ullrich S
Cell Physiol Biochem; 2015; 35(4):1537-45. PubMed ID: 25792236
[TBL] [Abstract][Full Text] [Related]
12. Octanoic acid potentiates glucose-stimulated insulin secretion and expression of glucokinase through the olfactory receptor in pancreatic β-cells.
Leem J; Shim HM; Cho H; Park JH
Biochem Biophys Res Commun; 2018 Sep; 503(1):278-284. PubMed ID: 29885841
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion.
Suckow AT; Polidori D; Yan W; Chon S; Ma JY; Leonard J; Briscoe CP
J Biol Chem; 2014 May; 289(22):15751-63. PubMed ID: 24742677
[TBL] [Abstract][Full Text] [Related]
14. Effects of hydroxyeicosatetraenoic acids on fatty acid esterification in phospholipids and insulin secretion in pancreatic islets.
Laychock SG
Endocrinology; 1985 Sep; 117(3):1011-9. PubMed ID: 3926463
[TBL] [Abstract][Full Text] [Related]
15. Niacin receptor GPR109A inhibits insulin secretion and is down-regulated in type 2 diabetic islet beta-cells.
Wang N; Guo DY; Tian X; Lin HP; Li YP; Chen SJ; Fu YC; Xu WC; Wei CJ
Gen Comp Endocrinol; 2016 Oct; 237():98-108. PubMed ID: 27570060
[TBL] [Abstract][Full Text] [Related]
16. Free fatty acid receptor 1 as a novel therapeutic target for type 2 diabetes mellitus-current status.
Eleazu C; Charles A; Eleazu K; Achi N
Chem Biol Interact; 2018 Jun; 289():32-39. PubMed ID: 29704509
[TBL] [Abstract][Full Text] [Related]
17. Glucose-Dependent Insulin Secretion in Pancreatic β-Cell Islets from Male Rats Requires Ca2+ Release via ROS-Stimulated Ryanodine Receptors.
Llanos P; Contreras-Ferrat A; Barrientos G; Valencia M; Mears D; Hidalgo C
PLoS One; 2015; 10(6):e0129238. PubMed ID: 26046640
[TBL] [Abstract][Full Text] [Related]
18. A FFAR1 full agonist restores islet function in models of impaired glucose-stimulated insulin secretion and diabetic non-human primates.
Rady B; Liu J; Huang H; Bakaj I; Qi J; Lee SP; Martin T; Norquay L; Player M; Pocai A
Front Endocrinol (Lausanne); 2022; 13():1061688. PubMed ID: 36482991
[TBL] [Abstract][Full Text] [Related]
19. Bombesin receptor subtype-3 (BRS-3) regulates glucose-stimulated insulin secretion in pancreatic islets across multiple species.
Feng Y; Guan XM; Li J; Metzger JM; Zhu Y; Juhl K; Zhang BB; Thornberry NA; Reitman ML; Zhou YP
Endocrinology; 2011 Nov; 152(11):4106-15. PubMed ID: 21878513
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of Glucose-stimulated Insulin Secretion by the GPR40-PLC-TRPC Pathway in Pancreatic β-Cells.
Yamada H; Yoshida M; Ito K; Dezaki K; Yada T; Ishikawa SE; Kakei M
Sci Rep; 2016 May; 6():25912. PubMed ID: 27180622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
